Is the Cipla play Torrent Pharma’s cowboy moment?

The quiet, conservative Ahmedabad-based drug maker is ready to pledge family silver to acquire a rival many times its size. The question is whether it can survive its ambition.

26 September, 202312 min
0
Banner image

Subscribe to read this story

We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.

$99 for one year

SUBSCRIBE
Already have an account? Sign In

Not ready to subscribe? Sign up for a free account

We value our free readers. Read 100+ stories every year.

You may also like

Business
Story image

Laurus Labs is Indian pharma’s dark horse

With a promoter who is unafraid to make bold bets and pivot to businesses holding more promise, investors can only look forward to better times.

Business
Story image

Has Aurobindo Pharma left its wild swings behind?

The Hyderabad-based generics maker has seen its stock scale all-time highs and lows in quick succession. With big plans in place and regulatory heat easing, its roller-coaster days may be over.

Business
Story image

Is Mankind Indian pharma’s next big star?

From making condoms to steering clear of costly formulations, the drugmaker’s strategy of taking the road less travelled could now give it a seat at the high table.